Generate Biomedicines Inc. to Participate in Goldman Sachs 47th Annual Global Healthcare Conference

Rhea-AI Summary

Generate Biomedicines (NASDAQ: GENB) plans to participate in the Goldman Sachs 47th Annual Global Healthcare Conference on Monday, June 8, 2026.

A live webcast and an archived replay are expected to be available on the company’s investor website under Events and Presentations.

News Market Reaction – GENB

+0.23%

1 alert

+0.23% Session close to close

$1.68B Market Cap

0.0x Rel. Volume

In the May 29 session, GENB gained 0.23%, reflecting a mild positive market reaction.

Data tracked by StockTitan Argus on the day of publication.

Market Context

This announcement highlights Generate Biomedicines’ upcoming participation in a major healthcare con...

Analysis

This announcement highlights Generate Biomedicines’ upcoming participation in a major healthcare conference and the availability of a webcast on June 8, 2026. It follows Q1 2026 results showing $516.6M in cash after IPO proceeds and ongoing investment in late-stage and early clinical programs. Investors may focus on any incremental strategic commentary or clinical color from the presentation relative to the previously disclosed earnings and pipeline updates.

Key Figures

Conference date: June 8, 2026 Current price: $13.09 24h price change: -1.95% +3 more

6 metrics

Conference date June 8, 2026 Goldman Sachs Global Healthcare Conference participation

Current price $13.09 Pre-news close on analysis date

24h price change -1.95% Move prior to conference announcement

52-week high $16.7484 Upper end of 52-week trading range

52-week low $11.00 Lower end of 52-week trading range

Market cap $1,676,757,691 Pre-news market capitalization

Historical Context

1 past event · Latest: May 07 (Negative)

Pattern 1 events

Date	Event	Sentiment	24h Move	Catalyst
May 07	Earnings and update	Negative	-11.2%	Q1 2026 loss of $61.7M offset by strong $516.6M cash position.

24h Move is the share-price change in the day after each event; other market factors may also have contributed.

Pattern Detected

Limited history shows the last earnings update was followed by a double-digit decline, indicating some sensitivity to fundamental news.

Recent Company History

Over the past months, Generate Biomedicines transitioned to public markets, reporting Q1 2026 results on May 7, 2026 with $7.2M revenue and a net loss of $61.7M. That update highlighted strong cash of $516.6M after IPO proceeds of $369.3M and ongoing late-stage trials. The new conference participation notice fits into a pattern of active investor communication following its IPO and initial quarterly reporting.

Key Terms

webcast

1 terms

webcast technical

"A live webcast is expected to be available in the Events and Presentations section"

A webcast is a live or recorded online event where people watch or listen to presentations, announcements, or performances through the internet. It’s like a TV broadcast but over the internet, allowing viewers from anywhere to tune in in real time or later. Webcasts are important because they let companies share information quickly and widely with audiences around the world.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

SOMERVILLE, Mass., May 28, 2026 /PRNewswire/ -- Generate Biomedicines, Inc. (NASDAQ: GENB) today announced that it intends to participate in the Goldman Sachs Global Healthcare Conference on Monday, June 8, 2026.

A live webcast is expected to be available in the Events and Presentations section of the Company's investor website at investors.generatebiomedicines.com. An archived replay is also expected to be available following the presentation.

About Generate:Biomedicines
Generate (NASDAQ: GENB) is a clinical-stage generative biology company founded at the intersection of machine learning, biological engineering, and medicine, advancing a new era of programmable biology to engineer better medicines for patients, faster. The Generate Platform integrates computational design with large-scale biological experimentation, enabling the creation of novel, optimized therapeutics that address historically undruggable and hard-to-drug targets, as well as known targets in new and more effective ways. The platform has enabled the generation of a broad pipeline of therapies across multiple therapeutic areas and protein-based modalities, addressing health challenges out of reach of traditional approaches. Founded in 2018, Generate is leading a fundamental shift from drug discovery to drug generation. Learn more at www.generatebiomedicines.com, or follow us on X, LinkedIn, and YouTube.

Generate Media Contact
Megan McLaughlin
pr@generatebiomedicines.com

View original content to download multimedia:https://www.prnewswire.com/news-releases/generate-biomedicines-inc-to-participate-in-goldman-sachs-47th-annual-global-healthcare-conference-302785001.html

SOURCE Generate:Biomedicines

FAQ

When will Generate Biomedicines (GENB) present at the Goldman Sachs 47th Annual Global Healthcare Conference?

Generate Biomedicines is scheduled to participate on Monday, June 8, 2026. According to the company, investors will be able to follow the appearance via a live webcast available in the Events and Presentations section of its investor relations website.

How can investors watch Generate Biomedicines (GENB) at the Goldman Sachs Global Healthcare Conference 2026?

Investors can watch via a live webcast on the company’s investor website. According to Generate Biomedicines, access will be provided in the Events and Presentations section, offering real-time viewing of the conference participation for shareholders and analysts.

Will a replay of Generate Biomedicines (GENB) 2026 Goldman Sachs healthcare conference presentation be available?

Yes, an archived replay is expected to be available after the presentation. According to Generate Biomedicines, the replay will be accessible on its investor relations site, allowing those who miss the live webcast to review the session later.

Where on the Generate Biomedicines (GENB) website will the Goldman Sachs 2026 conference webcast be hosted?

The webcast will be available in the Events and Presentations section of the investor website. According to Generate Biomedicines, both the live stream and archived replay will be hosted there for convenient access by investors and analysts.

What does Generate Biomedicines’ (GENB) participation in the Goldman Sachs 47th Global Healthcare Conference involve?

Participation involves Generate Biomedicines presenting at the Goldman Sachs healthcare event on June 8, 2026. According to the company, investors can follow the appearance through a live webcast and later replay, supporting broader visibility with the investment community.